Version 25.1.2

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.1.1

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.1.0

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.5

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.4

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.3

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.2

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.1

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).

Version 25.0.0

The data-depression-psiloctr dataset 📊

The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available.

This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article.

The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).